BiliStop is an evidence-based mobile application that provides scenario-specific assessment of the risks of rebound phototherapy for infants born more than 35 weeks of gestational age within 72 hours of first phototherapy termination.
Worldwide, hyperbilirubinemia is a leading cause for a baby to die or suffer neuro-development disabilities. Newborn phototherapy is an effective treatment, but like every medical treatment, has potential unintended side effects, including pediatric cancer and seizures. A recent large study found that more than 1/3 of infants may have been able to go home a day earlier with [less than] 4% risk of rebound jaundice.
BiliStop is based on the 2017 paper A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy, published in Pediatrics by Chang, et al . Newborn care providers respond to prompts about their patient’s clinical data. One of the data is the AAP threshold for phototherapy for the specific patient in his/her specific clinical scenario. This number can be calculated using the BiliTool TM free website. This App opens up this website for the user within the app, but does not calculate this number for the user.
BiliStop has been studied in a Mayo Clinic IRB approved clinical research , the results of which show that BiliStop is not only more accurate than hand calculation/calculation using a regular calculator, but also provides significantly better end-user satisfaction. The work was presented at the American Federation for Medical Research in 02/2020, and recently published in Neonatology Today in 08/2020.
The advantage of Bilistop:
-the number needed to treat (NNT) is 2.2 for 1 infant to benefit from its use.
-significantly higher user satisfaction than hand calculation
-most evidence based phototherapy termination decision tool
Potentially, utilizing BiliStop saves time on clinical rounds, and saves lives and health care dollars with its accuracy in assisting clinical decision making in neonatal jaundice.
BiliStop is intended for use by neonatologists, pediatricians, family medicine providers, neonatal nurse practitioners, medical residents, and medical students who treat newborn infants in the hospital and in outpatient settings. BiliStop should be used only as a reference aid and educational tool. The information required to put in this app are values commonly used in medical practice, and the result generated should not be used as a substitute for the clinician's clinical judgment. Please contact the developers if errors are found.
The developers shall not be held liable for any damages resulting from the use of this app. The developers reserve the rights to modify or discontinue BiliStop without notice.
Evergreen Bioinformatics LLC built the BiliStop app as a Commercial app.
This SERVICE is provided by Evergreen Bioinformatics LLC and is intended for use as is.
This page is used to inform visitors regarding our policies with the collection, use, and disclosure of Personal Information if anyone decided to use our Service.
If you choose to use our Service, then you agree to the collection and use of information in relation to this policy.
BiliStop does not;
This policy is effective as of 2020-05-10